219 related articles for article (PubMed ID: 36631161)
1. Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control.
Rodriguez-Ruiz ME; Serrano-Mendioroz I; Garate-Soraluze E; Sánchez-Mateos P; Barrio-Alonso C; Rodríguez López I; Diaz Pascual V; Arbea Moreno L; Alvarez M; Sanmamed MF; Perez-Gracia JL; Escuin-Ordinas H; Quintero M; Melero I
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36631161
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy.
Alvarez M; Molina C; De Andrea CE; Fernandez-Sendin M; Villalba M; Gonzalez-Gomariz J; Ochoa MC; Teijeira A; Glez-Vaz J; Aranda F; Sanmamed MF; Rodriguez-Ruiz ME; Fan X; Shen WH; Berraondo P; Quintero M; Melero I
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34824158
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapeutic effects of intratumoral nanoplexed poly I:C.
Aznar MA; Planelles L; Perez-Olivares M; Molina C; Garasa S; Etxeberría I; Perez G; Rodriguez I; Bolaños E; Lopez-Casas P; Rodriguez-Ruiz ME; Perez-Gracia JL; Marquez-Rodas I; Teijeira A; Quintero M; Melero I
J Immunother Cancer; 2019 May; 7(1):116. PubMed ID: 31046839
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C.
Gomar C; Di Trani CA; Bella A; Arrizabalaga L; Gonzalez-Gomariz J; Fernandez-Sendin M; Alvarez M; Russo-Cabrera JS; Ardaiz N; Aranda F; Schippers T; Quintero M; Melero I; Orlinger KK; Lauterbach H; Berraondo P
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631714
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic.
Alvarez M; Molina C; Garasa S; Ochoa MC; Rodriguez-Ruiz ME; Gomis G; Cirella A; Olivera I; Glez-Vaz J; Gonzalez-Gomariz J; Luri-Rey C; Azpilikueta A; Bolaños E; Teijeira A; Berraondo P; Quintero M; Melero I
Oncoimmunology; 2023; 12(1):2197370. PubMed ID: 37035637
[TBL] [Abstract][Full Text] [Related]
6. NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8
Walker JM; Rolig AS; Charych DH; Hoch U; Kasiewicz MJ; Rose DC; McNamara MJ; Hilgart-Martiszus IF; Redmond WL
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457127
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
[TBL] [Abstract][Full Text] [Related]
8. Immune mechanisms mediating abscopal effects in radioimmunotherapy.
Rodriguez-Ruiz ME; Rodriguez I; Leaman O; López-Campos F; Montero A; Conde AJ; Aristu JJ; Lara P; Calvo FM; Melero I
Pharmacol Ther; 2019 Apr; 196():195-203. PubMed ID: 30529041
[TBL] [Abstract][Full Text] [Related]
9. TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies.
Rodríguez-Ruiz ME; Rodríguez I; Mayorga L; Labiano T; Barbes B; Etxeberria I; Ponz-Sarvise M; Azpilikueta A; Bolaños E; Sanmamed MF; Berraondo P; Calvo FA; Barcelos-Hoff MH; Perez-Gracia JL; Melero I
Mol Cancer Ther; 2019 Mar; 18(3):621-631. PubMed ID: 30683810
[TBL] [Abstract][Full Text] [Related]
10. Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming.
Rodriguez-Ruiz ME; Rodriguez I; Garasa S; Barbes B; Solorzano JL; Perez-Gracia JL; Labiano S; Sanmamed MF; Azpilikueta A; Bolaños E; Sanchez-Paulete AR; Aznar MA; Rouzaut A; Schalper KA; Jure-Kunkel M; Melero I
Cancer Res; 2016 Oct; 76(20):5994-6005. PubMed ID: 27550452
[TBL] [Abstract][Full Text] [Related]
11. PD-1 blockade enhances radio-immunotherapy efficacy in murine tumor models.
Zhuang Y; Li S; Wang H; Pi J; Xing Y; Li G
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1909-1920. PubMed ID: 30074066
[TBL] [Abstract][Full Text] [Related]
12. PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8
Yoon YN; Lee E; Kwon YJ; Gim JA; Kim TJ; Kim JS
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288465
[TBL] [Abstract][Full Text] [Related]
13. Carbon ion irradiation plus CTLA4 blockade elicits therapeutic immune responses in a murine tumor model.
Hartmann L; Osen W; Eichmüller OL; Kordaß T; Furkel J; Dickes E; Reid C; Debus J; Brons S; Abdollahi A; Moustafa M; Rieken S; Eichmüller SB
Cancer Lett; 2022 Dec; 550():215928. PubMed ID: 36183858
[TBL] [Abstract][Full Text] [Related]
14. Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING.
Wang L; Luo R; Onyshchenko K; Rao X; Wang M; Menz B; Gaedicke S; Grosu AL; Firat E; Niedermann G
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37640480
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic immunization and local low-dose tumor irradiation, a reinforcing combination.
Draghiciu O; Walczak M; Hoogeboom BN; Franken KL; Melief KJ; Nijman HW; Daemen T
Int J Cancer; 2014 Feb; 134(4):859-72. PubMed ID: 23922012
[TBL] [Abstract][Full Text] [Related]
16. Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses.
Wei J; Montalvo-Ortiz W; Yu L; Krasco A; Ebstein S; Cortez C; Lowy I; Murphy AJ; Sleeman MA; Skokos D
Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33837124
[TBL] [Abstract][Full Text] [Related]
17. Effect of triple therapy with low-dose total body irradiation and hypo-fractionated radiation plus anti-programmed cell death protein 1 blockade on abscopal antitumor immune responses in breast cancer.
Liu S; Liao Y; Chen Y; Yang H; Hu Y; Chen Z; Fu S; Wu J
Int Immunopharmacol; 2023 Apr; 117():110026. PubMed ID: 36934673
[TBL] [Abstract][Full Text] [Related]
18. Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8
Rolig AS; Rose DC; McGee GH; Rubas W; Kivimäe S; Redmond WL
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35444059
[TBL] [Abstract][Full Text] [Related]
19. Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer.
Yuan M; Zhai Y; Men Y; Zhao M; Sun X; Ma Z; Bao Y; Yang X; Sun S; Liu Y; Zhang W; Hui Z
Oxid Med Cell Longev; 2022; 2022():5479491. PubMed ID: 35154567
[TBL] [Abstract][Full Text] [Related]
20. Methods to assess radiation induced abscopal responses in mice.
Garate-Soraluze E; Serrano-Mendioroz I; Rodriguez-Ruiz M
Methods Cell Biol; 2023; 180():81-92. PubMed ID: 37890934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
